Effect of nalbuphine and morphine as adjuvants to bupivacaine in ultrasound-guided supraclavicular block: a randomized controlled trial with machine learning-based predictive analysis

纳布啡和吗啡作为布比卡因辅助药物在超声引导下锁骨上神经阻滞中的应用效果:一项基于机器学习预测分析的随机对照试验

阅读:1

Abstract

BACKGROUND: Supraclavicular brachial plexus block is a commonly used regional anesthesia technique for upper extremity surgeries. The addition of adjuvants to local anesthetics enhances the duration and quality of anesthesia. Recently, Machine Learning (ML) has emerged as a tool for predictive modeling in medicine, including pain management. This study investigates the predictive capability of a K-Nearest Neighbor (KNN) ML model for analgesic duration using different drug combinations. METHODS: A prospective randomized controlled trial was conducted on 60 patients scheduled for upper limb surgeries under ultrasound-guided supraclavicular brachial plexus block. Patients were divided into three groups: Control (bupivacaine + saline), Nalbuphine (bupivacaine + nalbuphine), and Morphine (bupivacaine + morphine). The analgesic duration, sensory and motor block onset and duration, and postoperative analgesic use were recorded. A ML model, K-Nearest Neighbor (KNN), was developed to predict analgesic time based on demographic and hemodynamic parameters. RESULTS: Both nalbuphine and morphine significantly prolonged the duration of analgesia compared to the control group. The KNN model demonstrated a strong correlation (R = 0.95) between the observed and predicted analgesic duration, indicating high predictive accuracy. CONCLUSIONS: Nalbuphine and morphine significantly extended the analgesic duration of bupivacaine in ultrasound-guided supraclavicular brachial plexus block. ML models, such as KNN, offer effective tools for predicting analgesic outcomes and can assist anesthesiologists in making informed decisions regarding drug combinations for enhanced patient care. TRIAL REGISTRATION: ClinicalTrials.gov (NCT07008443). Registered in June 2025. Retrospectively registered. ClinicalTrials.gov is a primary registry in the WHO International Clinical Trials Registry Platform (ICTRP) network. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12871-025-03537-6.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。